Skip to content
OpenSampling

2025 · Clinical pharmacology and therapeutics · open access

Advancing Early Clinical Trials: The Transformative Potential of Decentralized Designs and Digital Technologies in Phase 1 Clinical Trial

Malhotra et al.

The finding, in our words

In a Phase 1 crossover study of etrasimod, self-collected blood microsamples yielded pharmacokinetic exposures comparable to conventional venous sampling, both with and without participant practice sessions. Continuous wearable sensors concurrently enabled real-time remote monitoring of safety vital signs and electrocardiograms, demonstrating the viability of hybrid decentralised designs in early-phase clinical trials.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2025

    In this decentralised n-of-1 crossover trial of dapagliflozin in 20 adults with type 2 diabetes, remote collection of urine and capillary blood samples achieved 99.4% and 98.4% delivery success respectively, demonstrating that remote monitoring can reliably track individual albuminuria responses to therapy.

    Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover TrialBeernink et al., JAMA network open · source ↗

    • dct
    • multimodal
    • blood
    • rpm
    • self-collection
    • capillary
    • urine
    • biomarkers
  2. 2023

    The study found that smartwatch-based adherence monitoring showed consistent concordance over time and may be more reliable than app or pill count methods in measuring treatment adherence in a decentralised setting. This supports the use of wearable devices as objective tools in patient-centric monitoring for decentralised clinical trials.

    Exploration of smart adherence-monitoring methods in vitamin D-deficient patients: A pilot feasibility clinical studyHuh et al., Clinical and translational science · source ↗

    • dct
    • wearable
    • multimodal
    • blood
    • rpm
    • digital-biomarker
    • biomarkers
  3. 2023

    Decentralised monitoring of people with type 2 diabetes using continuous glucose monitoring and a hybrid smartwatch was feasible, with high participant retention and successful collection of glucose, heart rate, activity, sleep and GPS data via a study app.

    Exploring Decentralized Glucose and Behaviometric Monitoring of Persons with Type 2 Diabetes in the Setting of a Clinical TrialAli et al., Journal of diabetes science and technology (paywalled) · source ↗

    • dct
    • actigraphy
    • wearable
    • multimodal
    • cgm
    • rpm
    • self-collection
    • digital-biomarker
    • interstitial-fluid
  4. 2026

    This proof-of-concept study demonstrated that patients with inflammatory bowel disease could successfully perform capillary blood microsampling at home with high analytical success rates, and a majority preferred this decentralised approach over hospital venous draws.

    Implementation of a Capillary Blood Self-Sampling Technique at Home for Monitoring of Patients With IBDSchuurman et al., Inflammatory bowel diseases · source ↗

    • acceptability
    • multimodal
    • blood
    • rpm
    • self-collection
    • capillary
    • liquid
  5. 2026

    This study found strong concordance between capillary samples collected via the Tasso device and standard venous draws for VirScan serology, indicating that self-collected samples are a practical alternative for decentralised research. The authors advise against interchanging these collection methods within a single longitudinal study to avoid introducing technical variability.

    Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling deviceSircy et al., Microbiology spectrum · source ↗

    • dct
    • venous-agreement
    • blood
    • self-collection
    • serology
    • capillary
    • liquid